Identification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Figueroa Romero, Claudia ^a   Hur, Junguk ^a   Bender, Diane E ^a   Delaney, Colin E ^a   Cataldo, Michael D ^a   Smith, Andrea L ^a   Yung, Raymond ^a   Ruden, Douglas M ^b   Callaghan, Brian C ^a   Feldman, Eva L ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; HYDROXYMETHYLATION; IMMUNE SYSTEM; INFLAMMATION; MALE; METHYLATION; METHYLOMICS; PATHOGENESIS; REGULATORY MECHANISM; SPINAL CORD; TRANSCRIPTOMICS;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CASE-CONTROL STUDIES; CYTIDINE; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; SPINAL CORD; TRANSCRIPTOME;

EID: 84871536769     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052672     Document Type: Article

References (93)

1. de Carvalho M, Swash M, (2011) Amyotrophic lateral sclerosis: an update. Curr Opin Neurol 24: 497-503.
2. Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ, (2011) Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 7: 616-630.
3. Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, et al. (2006) Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 103: 16021-16026.
4. ALSoD: ALS Online Genetic Database. Available: http://alsod.iop.kcl.ac.uk/. Accessed1 August 2012.
5. Siddique T, Ajroud-Driss S, (2011) Familial amyotrophic lateral sclerosis, a historical perspective. Acta Myol 30: 117-120.
6. van Blitterswijk M, van Es MA, Koppers M, van Rheenen W, Medic J, et al. (2012) VAPB and C9orf72 mutations in 1 familial amyotrophic lateral sclerosis patient. Neurobiol Aging 33: 2950 e2951-2954.
7. Ahmed A, Wicklund MP, (2011) Amyotrophic lateral sclerosis: what role does environment play? Neurol Clin 29: 689-711.
8. Qureshi IA, Mehler MF, (2011) Advances in epigenetics and epigenomics for neurodegenerative diseases. Curr Neurol Neurosci Rep 11: 464-473.
9. Cortessis VK, Thomas DC, Levine AJ, Breton CV, Mack TM, et al. (2012) Environmental epigenetics: prospects for studying epigenetic mediation of exposure-response relationships. Hum Genet 131: 1565-1589.
10. Dawson MA, Kouzarides T, (2012) Cancer epigenetics: from mechanism to therapy. Cell 150: 12-27.
11. Irier HA, Jin P, (2012) Dynamics of DNA methylation in aging and Alzheimer's disease. DNA Cell Biol 31Suppl 1: S42-48.
12. Ito S, Shen L, Dai Q, Wu SC, Collins LB, et al. (2011) Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333: 1300-1303.
13. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, et al. (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324: 930-935.
14. Chen ZX, Riggs AD, (2011) DNA methylation and demethylation in mammals. J Biol Chem 286: 18347-18353.
15. Chestnut BA, Chang Q, Price A, Lesuisse C, Wong M, et al. (2011) Epigenetic regulation of motor neuron cell death through DNA methylation. J Neurosci 31: 16619-16636.
16. Calvo A, Moglia C, Balma M, Chio A, (2010) Involvement of immune response in the pathogenesis of amyotrophic lateral sclerosis: a therapeutic opportunity? CNS Neurol Disord Drug Targets 9: 325-330.
17. Hashioka S, Klegeris A, Schwab C, McGeer PL, (2009) Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells. Neurobiol Aging 30: 1924-1935.
18. Makrantonaki E, Zouboulis CC, (2007) The skin as a mirror of the aging process in the human organism-state of the art and results of the aging research in the German National Genome Research Network 2 (NGFN-2). Exp Gerontol 42: 879-886.
19. Bae SI, Cheriyath V, Jacobs BS, Reu FJ, Borden EC, (2008) Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL. Oncogene 27: 490-498.
20. Crispi S, Sanzari E, Monfregola J, De Felice N, Fimiani G, et al. (2004) Characterization of the human STAT5A and STAT5B promoters: evidence of a positive and negative mechanism of transcriptional regulation. FEBS Lett 562: 27-34.
21. DeBaun MR, Niemitz EL, Feinberg AP, (2003) Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am J Hum Genet 72: 156-160.
22. Kim JH, Kang HS, Kim TW, Kim SJ, (2011) Differential methylation hybridization profiling identifies involvement of STAT1-mediated pathways in breast cancer. Int J Oncol 39: 955-963.
23. Lee YM, (2011) Control of RUNX3 by histone methyltransferases. J Cell Biochem 112: 394-400.
24. Inoue K, Shiga T, Ito Y, (2008) Runx transcription factors in neuronal development. Neural Dev 3: 20.
25. Marron TU, Guerini V, Rusmini P, Sau D, Brevini TA, et al. (2005) Androgen-induced neurite outgrowth is mediated by neuritin in motor neurones. J Neurochem 92: 10-20.
26. Medina M, Marinescu RC, Overhauser J, Kosik KS, (2000) Hemizygosity of delta-catenin (CTNND2) is associated with severe mental retardation in cri-du-chat syndrome. Genomics 63: 157-164.
27. Ramos C, Robert B, (2005) msh/Msx gene family in neural development. Trends Genet 21: 624-632.
28. Teijido O, Casaroli-Marano R, Kharkovets T, Aguado F, Zorzano A, et al. (2007) Expression patterns of MLC1 protein in the central and peripheral nervous systems. Neurobiol Dis 26: 532-545.
29. Wang Q, Lu QJ, Xiao B, Zheng Y, Wang XM, (2011) Expressions of Axl and Tyro-3 receptors are under regulation of nerve growth factor and are involved in differentiation of PC12 cells. Neurosci Bull 27: 15-22.
30. Zheng S, Chou AH, Jimenez AL, Khodadadi O, Son S, et al. (2002) The fetal and neonatal brain protein neuronatin protects PC12 cells against certain types of toxic insult. Brain Res Dev Brain Res 136: 101-110.
31. Chen H, Dzitoyeva S, Manev H, (2012) Effect of aging on 5-hydroxymethylcytosine in the mouse hippocampus. Restor Neurol Neurosci 30: 237-245.
32. Frijters R, Heupers B, van Beek P, Bouwhuis M, van Schaik R, et al. (2008) CoPub: a literature-based keyword enrichment tool for microarray data analysis. Nucleic Acids Res 36: W406-410.
33. Nestor CE, Ottaviano R, Reddington J, Sproul D, Reinhardt D, et al. (2012) Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res 22: 467-477.
34. van den Hove DL, Chouliaras L, Rutten BP, (2012) The role of 5-hydroxymethylcytosine in aging and Alzheimer's disease: current status and prospects for future studies. Curr Alzheimer Res 9: 545-549.
35. Yang HH, Hu N, Wang C, Ding T, Dunn BK, et al. (2010) Influence of genetic background and tissue types on global DNA methylation patterns. PLoS One 5: e9355.
36. Bollati V, Galimberti D, Pergoli L, Dalla Valle E, Barretta F, et al. (2011) DNA methylation in repetitive elements and Alzheimer disease. Brain Behav Immun 25: 1078-1083.
37. Coppede F, (2011) An overview of DNA repair in amyotrophic lateral sclerosis. ScientificWorldJournal 11: 1679-1691.
38. Kisby GE, Milne J, Sweatt C, (1997) Evidence of reduced DNA repair in amyotrophic lateral sclerosis brain tissue. Neuroreport 8: 1337-1340.
39. Dangond F, Hwang D, Camelo S, Pasinelli P, Frosch MP, et al. (2004) Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol Genomics 16: 229-239.
40. Ishigaki S, Niwa J, Ando Y, Yoshihara T, Sawada K, et al. (2002) Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords-screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett 531: 354-358.
41. Malaspina A, Kaushik N, de Belleroche J, (2001) Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem 77: 132-145.
42. Eklow C, Makrygiannakis D, Backdahl L, Padyukov L, Ulfgren AK, et al. (2008) Cellular distribution of the C-type II lectin dendritic cell immunoreceptor (DCIR) and its expression in the rheumatic joint: identification of a subpopulation of DCIR+ T cells. Ann Rheum Dis 67: 1742-1749.
43. Miah SM, Hughes TL, Campbell KS, (2008) KIR2DL4 differentially signals downstream functions in human NK cells through distinct structural modules. J Immunol 180: 2922-2932.
44. Piccio L, Buonsanti C, Mariani M, Cella M, Gilfillan S, et al. (2007) Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 37: 1290-1301.
45. Butovsky O, Siddiqui S, Gabriely G, Lanser AJ, Dake B, et al. (2012) Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest 122: 3063-3087.
46. Zhang R, Gascon R, Miller RG, Gelinas DF, Mass J, et al. (2005) Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol 159: 215-224.
47. Smith SA, Miller RG, Murphy JR, Ringel SP, (1994) Treatment of ALS with high dose pulse cyclophosphamide. J Neurol Sci 124Suppl: 84-87.
48. Tanaka K, Kanno T, Yanagisawa Y, Yasutake K, Hadano S, et al. (2011) Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis. Exp Neurol 232: 41-52.
49. Van Den Bosch L, Tilkin P, Lemmens G, Robberecht W, (2002) Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport 13: 1067-1070.
50. Werdelin L, Boysen G, Jensen TS, Mogensen P, (1990) Immunosuppressive treatment of patients with amyotrophic lateral sclerosis. Acta Neurol Scand 82: 132-134.
51. Shaw PJ, (2005) Molecular and cellular pathways of neurodegeneration in motor neurone disease. J Neurol Neurosurg Psychiatry 76: 1046-1057.
52. Valentine JS, Doucette PA, Zittin Potter S, (2005) Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 74: 563-593.
53. Ramji DP, Vitelli A, Tronche F, Cortese R, Ciliberto G, (1993) The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBP delta/NF-IL6 beta, are induced by IL-6 to promote acute phase gene transcription via different mechanisms. Nucleic Acids Res 21: 289-294.
54. Valente T, Mancera P, Tusell JM, Serratosa J, Saura J, (2012) C/EBPbeta expression in activated microglia in amyotrophic lateral sclerosis. Neurobiol Aging 33: 2186-2199.
55. Deforges S, Branchu J, Biondi O, Grondard C, Pariset C, et al. (2009) Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J Physiol 587: 3561-3572.
56. Ting CH, Lin CW, Wen SL, Hsieh-Li HM, Li H, (2007) Stat5 constitutive activation rescues defects in spinal muscular atrophy. Hum Mol Genet 16: 499-514.
57. Xu J, Chen S, Chen H, Xiao Q, Hsu CY, et al. (2009) STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes. J Neurosci 29: 2022-2026.
58. Bacon C, Endris V, Rappold G, (2009) Dynamic expression of the Slit-Robo GTPase activating protein genes during development of the murine nervous system. J Comp Neurol 513: 224-236.
59. Pellikka M, Tanentzapf G, Pinto M, Smith C, McGlade CJ, et al. (2002) Crumbs, the Drosophila homologue of human CRB1/RP12, is essential for photoreceptor morphogenesis. Nature 416: 143-149.
60. Jun G, Moncaster JA, Koutras C, Seshadri S, Buros J, et al. (2012) delta-Catenin is genetically and biologically associated with cortical cataract and future Alzheimer-related structural and functional brain changes. PLoS One 7: e43728.
61. Kudo LC, Parfenova L, Vi N, Lau K, Pomakian J, et al. (2010) Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis. Hum Mol Genet 19: 3233-3253.
62. Ratovitski T, Chighladze E, Waldron E, Hirschhorn RR, Ross CA, (2011) Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtin. J Biol Chem 286: 12578-12589.
63. Gonzalez de Aguilar JL, Niederhauser-Wiederkehr C, Halter B, De Tapia M, Di Scala F, et al. (2008) Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model. Physiol Genomics 32: 207-218.
64. Offen D, Barhum Y, Melamed E, Embacher N, Schindler C, et al. (2009) Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant. J Mol Neurosci 38: 85-93.
65. Maruyama H, Morino H, Ito H, Izumi Y, Kato H, et al. (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465: 223-226.
66. Morahan JM, Yu B, Trent RJ, Pamphlett R, (2007) Are metallothionein genes silenced in ALS? Toxicol Lett 168: 83-87.
67. Oates N, Pamphlett R, (2007) An epigenetic analysis of SOD1 and VEGF in ALS. Amyotroph Lateral Scler 8: 83-86.
68. Jiang YM, Yamamoto M, Kobayashi Y, Yoshihara T, Liang Y, et al. (2005) Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol 57: 236-251.
69. Wang XS, Simmons Z, Liu W, Boyer PJ, Connor JR, (2006) Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling the post mortem cortex. Amyotroph Lateral Scler 7: 201-210.
70. Lederer CW, Torrisi A, Pantelidou M, Santama N, Cavallaro S, (2007) Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics 8: 26.
71. Morahan JM, Yu B, Trent RJ, Pamphlett R, (2009) A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10: 418-429.
72. Kirby J, Ning K, Ferraiuolo L, Heath PR, Ismail A, et al. (2011) Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain 134: 506-517.
73. Lokk K, Vooder T, Kolde R, Valk K, Vosa U, et al. (2012) Methylation markers of early-stage non-small cell lung cancer. PLoS One 7: e39813.
74. Rishi V, Bhattacharya P, Chatterjee R, Rozenberg J, Zhao J, et al. (2010) CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes. Proc Natl Acad Sci U S A 107: 20311-20316.
75. Shenker N, Flanagan JM, (2012) Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research. Br J Cancer 106: 248-253.
76. Szulwach KE, Li X, Smrt RD, Li Y, Luo Y, et al. (2010) Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol 189: 127-141.
77. Connolly R, Stearns V (2012) Epigenetics as a Therapeutic Target in Breast Cancer. J Mammary Gland Biol Neoplasia.
78. Gray SG, Dangond F, (2006) Rationale for the use of histone deacetylase inhibitors as a dual therapeutic modality in multiple sclerosis. Epigenetics 1: 67-75.
79. Illumina I (2008) GenomeStudio Gene Expression Module v1.0 User Guide. Illumina. 97-107.
80. Hur J, Sullivan KA, Pande M, Hong Y, Sima AA, et al. (2011) The identification of gene expression profiles associated with progression of human diabetic neuropathy. Brain 134: 3222-3235.
81. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, et al. (2006) GenePattern 2.0. Nat Genet 38: 500-501.
82. Dai M, Wang P, Boyd AD, Kostov G, Athey B, et al. (2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33: e175.
83. Gautier L, Cope L, Bolstad BM, Irizarry RA, (2004) affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20: 307-315.
84. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
85. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
86. Sartor MA, Tomlinson CR, Wesselkamper SC, Sivaganesan S, Leikauf GD, et al. (2006) Intensity-based hierarchical Bayes method improves testing for differentially expressed genes in microarray experiments. BMC Bioinformatics 7: 538.
87. Huang da W, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
88. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
89. Hur J, Schuyler AD, States DJ, Feldman EL, (2009) SciMiner: web-based literature mining tool for target identification and functional enrichment analysis. Bioinformatics 25: 838-840.
90. Hur J, Sullivan KA, Schuyler AD, Hong Y, Pande M, et al. (2010) Literature-based discovery of diabetes- and ROS-related targets. BMC Med Genomics 3: 49.
91. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, et al. (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942.
92. McGeer PL, McGeer EG, (2002) Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26: 459-470.
93. Estecio MR, Gharibyan V, Shen L, Ibrahim AE, Doshi K, et al. (2007) LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One 2: e399.